Viewing Study NCT01857895


Ignite Creation Date: 2025-12-24 @ 1:52 PM
Ignite Modification Date: 2026-02-01 @ 5:36 PM
Study NCT ID: NCT01857895
Status: COMPLETED
Last Update Posted: 2017-10-19
First Post: 2013-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nausea View
None subcutaneous infusion View
None exenatide View